Al-Ola Abdallah, Associate Professor Of Medicine at University of Kansas Medical Center, shared a post on LinkedIn:
“Identifying Limitations to CAR T-Cell Therapies in Large B-Cell Lymphoma
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, at the 2025 National Immune Cell Effector Therapy (ICE_T) conference in Orlando, Florida via Cancer Network.”
More posts featuring Al-Ola Abdallah on OncoDaily.